Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

Clinical trial NCT06991361 · RECRUITING

Trial details

NCT number: NCT06991361
Sponsor: Leslie Kean
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Graft Versus Host Disease (cGvHD)

Start date: 2026-05-29
Primary completion: 2029-05-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.